Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge modelResearch in context
Summary: Background: The tick-borne bunyavirus, Crimean-Congo Haemorrhagic Fever virus (CCHFV), can cause severe febrile illness in humans and has a wide geographic range that continues to expand due to tick migration. Currently, there are no licensed vaccines against CCHFV for widespread usage. Me...
Main Authors: | Jack E. Saunders, Ciaran Gilbride, Stuart Dowall, Susan Morris, Marta Ulaszewska, Alexandra J. Spencer, Emma Rayner, Victoria A. Graham, Emma Kennedy, Kelly Thomas, Roger Hewson, Sarah C. Gilbert, Sandra Belij-Rammerstorfer, Teresa Lambe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423000889 |
Similar Items
-
Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera
by: Sandra Belij-Rammerstorfer, et al.
Published: (2022-08-01) -
Detection of Crimean–Congo Haemorrhagic Fever Virus from Livestock Ticks in Northern, Central and Southern Senegal in 2021
by: Aminata Badji, et al.
Published: (2023-06-01) -
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
by: Ujjwal Neogi, et al.
Published: (2022-04-01) -
Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model
by: Sarah Kempster, et al.
Published: (2024-08-01) -
Development of targeted whole genome sequencing approaches for Crimean-Congo haemorrhagic fever virus (CCHFV)
by: Jake D'Addiego, et al.
Published: (2024-12-01)